Overview
The premier international journal covering the disciplines of pharmacovigilance, pharmacoepidemiology, benefit-risk assessment, risk management and medication error prevention. Drug Safety advances the rational use of pharmacotherapy by publishing reviews and original research articles offering guidance for safe and effective drug utilization and prescribing.
As a hybrid journal, Drug Safety does not charge authors to publish using the traditional subscription-based publishing route, but does offer the option to publish accepted articles open access if authors so wish or if their funders require (more information).
Drug Safety also offers a range of additional features designed to increase the visibility, readership and educational value of the journal’s content (more information).
Drug Safety is the official journal of the International Society of Pharmacovigilance (ISoP). The official representative for the Society is Dr Angela Caro Rojas, ISoP President (administration@isoponline.org).
- Editor
-
- Nitin Joshi
- Impact factor
- 4.2 (2022)
- 5 year impact factor
- 4.3 (2022)
- Submission to first decision (median)
- 20 days
- Downloads
- 819,378 (2023)
Societies and partnerships
Latest articles
Journal updates
-
Digital Features
Drug Safety is able to host a range of digital features, with a number of options available to authors.
Journal information
- Electronic ISSN
- 1179-1942
- Print ISSN
- 0114-5916
- Abstracted and indexed in
-
- BFI List
- BIOSIS
- Baidu
- CLOCKSS
- CNKI
- CNPIEC
- Chemical Abstracts Service (CAS)
- Current Contents/Clinical Medicine
- Dimensions
- EBSCO
- EMBASE
- EMCare
- Google Scholar
- Japanese Science and Technology Agency (JST)
- Medline
- Naver
- OCLC WorldCat Discovery Service
- Pathway Studio
- Portico
- ProQuest
- Reaxys
- SCImago
- SCOPUS
- Science Citation Index Expanded (SCIE)
- Semantic Scholar
- TD Net Discovery Service
- UGC-CARE List (India)
- Wanfang
- Copyright information